Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/28357
Title: | Variants in ATP6V0A1 cause progressive myoclonus epilepsy and developmental and epileptic encephalopathy. | Austin Authors: | Bott, Laura C;Forouhan, Mitra;Lieto, Maria;Sala, Ambre J;Ellerington, Ruth;Johnson, Janel O;Speciale, Alfina A;Criscuolo, Chiara;Filla, Alessandro;Chitayat, David;Alkhunaizi, Ebba;Shannon, Patrick;Nemeth, Andrea H;Angelucci, Francesco;Lim, Wooi Fang;Striano, Pasquale;Zara, Federico;Helbig, Ingo;Muona, Mikko;Courage, Carolina;Lehesjoki, Anna-Elina;Berkovic, Samuel F ;Fischbeck, Kenneth H;Brancati, Francesco;Morimoto, Richard I;Wood, Matthew J A;Rinaldi, Carlo | Affiliation: | Epilepsy Research Centre Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, Naples 80121, Italy Institute for Research, Hospitalization and Health Care (IRCCS) "G. Gaslini" Institute, Genova 16147, Italy Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK Department of Neurology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA Oxford Harrington Rare Disease Centre, University of Oxford, Oxford OX1 3QX, UK Department of Physiology, Anatomy and Genetics, Oxford OX1 3QX, UK Division of Clinical and Metabolic Genetics, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada The Prenatal Diagnosis and Medical Genetics Program, Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario M5G 1X5, Canada Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA The Epilepsy NeuroGenetics Initiative (ENGIN), Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA Department of Biomedical and Health Informatics (DBHi), Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA Blueprint Genetics, 02150 Espoo, Finland Folkhälsan Research Center, Helsinki, Finland Department of Medical and Clinical Genetics, Medicum, University of Helsinki, Helsinki, 00290, Finland Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 Coppito, L'Aquila, Italy Department of Paediatrics, University of Oxford, Oxford OX1 3QX, UK Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, MD 20892, USA Department of Molecular Biosciences, Rice Institute for Biomedical Research, Northwestern University, Evanston, IL 60208, USA Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario M5G 1X5, Canada IRCCS San Raffaele Pisana, 00163 Roma, Italy |
Issue Date: | 2021 | Date: | 2021 | Publication information: | Brain Communications 2021; 3(4): fcab245 | Abstract: | The vacuolar H+-ATPase is a large multi-subunit proton pump, composed of an integral membrane V0 domain, involved in proton translocation, and a peripheral V1 domain, catalysing ATP hydrolysis. This complex is widely distributed on the membrane of various subcellular organelles, such as endosomes and lysosomes, and plays a critical role in cellular processes ranging from autophagy to protein trafficking and endocytosis. Variants in ATP6V0A1, the brain-enriched isoform in the V0 domain, have been recently associated with developmental delay and epilepsy in four individuals. Here, we identified 17 individuals from 14 unrelated families with both with new and previously characterized variants in this gene, representing the largest cohort to date. Five affected subjects with biallelic variants in this gene presented with a phenotype of early-onset progressive myoclonus epilepsy with ataxia, while 12 individuals carried de novo missense variants and showed severe developmental and epileptic encephalopathy. The R740Q mutation, which alone accounts for almost 50% of the mutations identified among our cases, leads to failure of lysosomal hydrolysis by directly impairing acidification of the endolysosomal compartment, causing autophagic dysfunction and severe developmental defect in Caenorhabditis elegans. Altogether, our findings further expand the neurological phenotype associated with variants in this gene and provide a direct link with endolysosomal acidification in the pathophysiology of ATP6V0A1-related conditions. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/28357 | DOI: | 10.1093/braincomms/fcab245 | ORCID: | https://orcid.org/0000-0003-4014-3113 https://orcid.org/0000-0003-4580-841X https://orcid.org/0000-0002-6065-1476 |
Journal: | Brain Communications | PubMed URL: | 34909687 | PubMed URL: | https://pubmed.ncbi.nlm.nih.gov/34909687/ | Type: | Journal Article | Subjects: | Caenorhabditis elegans disease modelling V-ATPase epileptic encephalopathy lysosomal disease organelle acidification |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.